SASP: Tumor Suppressor or Promoter? Yes!

Perez-Mancera, 2014, Inside and out: the activities of senescence in cancer, Nat. Rev. Cancer, 14, 547, 10.1038/nrc3773

Hayflick, 1965, The limited in vitro lifetime of human diploid cell strains, Exp. Cell Res., 37, 614, 10.1016/0014-4827(65)90211-9

Lowe, 2004, Intrinsic tumour suppression, Nature, 432, 307, 10.1038/nature03098

Campisi, 2001, Cellular senescence as a tumor-suppressor mechanism, Trends Cell Biol., 11, S27, 10.1016/S0962-8924(01)02151-1

Tonnessen-Murray, 2016, The regulation of cellular functions by the p53 protein: cellular senescence, 173

Kuilman, 2010, The essence of senescence, Genes. Dev., 24, 2463, 10.1101/gad.1971610

Campisi, 2005, Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors, Cell, 120, 513, 10.1016/j.cell.2005.02.003

Hornsby, 2002, Cellular senescence and tissue aging in vivo, J. Gerontol. A. Biol. Sci. Med. Sci., 57, B251, 10.1093/gerona/57.7.B251

Baker, 2011, Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders, Nature, 479, 232, 10.1038/nature10600

Baker, 2016, Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan, Nature, 530, 184, 10.1038/nature16932

Collado, 2010, Senescence in tumours: evidence from mice and humans, Nat. Rev. Cancer, 10, 51, 10.1038/nrc2772

Sharpless, 2015, Forging a signature of in vivo senescence, Nat. Rev. Cancer, 15, 397, 10.1038/nrc3960

Chang, 1999, A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents, Cancer Res., 59, 3761

Shay, 2004, Hallmarks of senescence in carcinogenesis and cancer therapy, Oncogene, 23, 2919, 10.1038/sj.onc.1207518

Malaquin, 2016, Keeping the senescence secretome under control: molecular reins on the senescence-associated secretory phenotype, Exp. Gerontol., 82, 39, 10.1016/j.exger.2016.05.010

Rodier, 2009, Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion, Nat. Cell Biol., 11, 973, 10.1038/ncb1909

Coppe, 2011, Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype, J. Biol. Chem., 286, 36396, 10.1074/jbc.M111.257071

Coppe, 2008, Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor, PLoS Biol., 6, 2853, 10.1371/journal.pbio.0060301

Vallabhapurapu, 2009, Regulation and function of NF-kappaB transcription factors in the immune system, Annu. Rev. Immunol., 27, 693, 10.1146/annurev.immunol.021908.132641

Acosta, 2008, Chemokine signaling via the CXCR2 receptor reinforces senescence, Cell, 133, 1006, 10.1016/j.cell.2008.03.038

Chien, 2011, Control of the senescence-associated secretory phenotype by NF-kappaB promotes senescence and enhances chemosensitivity, Genes Dev., 25, 2125, 10.1101/gad.17276711

Hardy, 2005, Transcriptional networks and cellular senescence in human mammary fibroblasts, Mol. Biol. Cell, 16, 943, 10.1091/mbc.e04-05-0392

Ohanna, 2011, Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome (PNAS), Genes Dev., 25, 1245, 10.1101/gad.625811

Wang, 2009, RelA/p65 functions to maintain cellular senescence by regulating genomic stability and DNA repair, EMBO Rep., 10, 1272, 10.1038/embor.2009.197

Rovillain, 2011, Activation of nuclear factor-kappa B signalling promotes cellular senescence, Oncogene, 30, 2356, 10.1038/onc.2010.611

Freund, 2011, p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype, EMBO J., 30, 1536, 10.1038/emboj.2011.69

Janssens, 2006, Signals from within: the DNA-damage-induced NF-kappaB response, Cell Death Differ., 13, 773, 10.1038/sj.cdd.4401843

Olivieri, 2015, DNA damage response (DDR) and senescence: shuttled inflamma-miRNAs on the stage of inflamm-aging, Oncotarget, 6, 35509, 10.18632/oncotarget.5899

Alexander, 2013, IkappaBzeta is a regulator of the senescence-associated secretory phenotype in DNA damage- and oncogene-induced senescence, J. Cell Sci., 126, 3738, 10.1242/jcs.128835

Ohanna, 2013, Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype, Oncotarget, 4, 2212, 10.18632/oncotarget.1143

Jackson, 2012, p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer, Cancer Cell, 21, 793, 10.1016/j.ccr.2012.04.027

Canino, 2012, SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells, Oncogene, 31, 3148, 10.1038/onc.2011.485

Kang, 2015, The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4, Science, 349, aaa5612, 10.1126/science.aaa5612

te Poele, 2002, DNA damage is able to induce senescence in tumor cells in vitro and in vivo, Cancer Res., 62, 1876

Jackson, 2006, Primary and compensatory roles for RB family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin-induced senescence of breast cancer cells, Mol. Cell Biol., 26, 2501, 10.1128/MCB.26.7.2501-2510.2006

Symmans, 2007, Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy, J. Clin. Oncol., 25, 4414, 10.1200/JCO.2007.10.6823

Bertheau, 2008, TP53 status and response to chemotherapy in breast cancer, Pathobiology, 75, 132, 10.1159/000123851

Murphy, 2012

Pyzer, 2016, Myeloid-derived suppressor cells as effectors of immune suppression in cancer, Int. J. Cancer, 39, 1915, 10.1002/ijc.30232

Kuilman, 2008, Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network, Cell, 133, 1019, 10.1016/j.cell.2008.03.039

Wajapeyee, 2008, Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7, Cell, 132, 10.1016/j.cell.2007.12.032

Guo, 2013, Chemokine receptor CXCR2 is transactivated by p53 and induces p38-mediated cellular senescence in response to DNA damage, Aging Cell, 12, 1110, 10.1111/acel.12138

Acosta, 2013, A complex secretory program orchestrated by the inflammasome controls paracrine senescence, Nat. Cell Biol., 15, 978, 10.1038/ncb2784

Kang, 2011, Senescence surveillance of pre-malignant hepatocytes limits liver cancer development, Nature, 479, 547, 10.1038/nature10599

Tasdemir, 2016, BRD4 connects enhancer remodeling to senescence immune surveillance, Cancer Discov., 6, 612, 10.1158/2159-8290.CD-16-0217

Iannello, 2013, p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells, J. Exp. Med., 210, 2057, 10.1084/jem.20130783

Xue, 2007, Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas, Nature, 445, 656, 10.1038/nature05529

Krizhanovsky, 2008, Senescence of activated stellate cells limits liver fibrosis, Cell, 134, 657, 10.1016/j.cell.2008.06.049

Lujambio, 2013, Non-cell-autonomous tumor suppression by p53, Cell, 153, 449, 10.1016/j.cell.2013.03.020

Kansara, 2013, Immune response to RB1-regulated senescence limits radiation-induced osteosarcoma formation, J. Clin. Invest., 123, 5351, 10.1172/JCI70559

Lesina, 2016, RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis, J. Clin. Invest., 126, 2919, 10.1172/JCI86477

Pribluda, 2013, A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism, Cancer Cell, 24, 242, 10.1016/j.ccr.2013.06.005

Marmary, 2016, Radiation-induced loss of salivary gland function is driven by cellular senescence and prevented by IL6 modulation, Cancer Res., 76, 1170, 10.1158/0008-5472.CAN-15-1671

Krtolica, 2001, Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging, Proc. Natl. Acad. Sci. U.S.A., 98, 12072, 10.1073/pnas.211053698

Parrinello, 2005, Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation, J. Cell Sci., 118, 485, 10.1242/jcs.01635

Liu, 2007, Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion, Cancer Res., 67, 3117, 10.1158/0008-5472.CAN-06-3452

Gosselin, 2009, Senescence-associated oxidative DNA damage promotes the generation of neoplastic cells, Cancer Res., 69, 7917, 10.1158/0008-5472.CAN-08-2510

Malaquin, 2013, Senescent fibroblasts enhance early skin carcinogenic events via a paracrine MMP-PAR-1 axis, PLoS ONE, 8, e63607, 10.1371/journal.pone.0063607

Bhatia, 2008, Evidence that senescent human prostate epithelial cells enhance tumorigenicity: cell fusion as a potential mechanism and inhibition by p16INK4a and hTERT, Int. J. Cancer, 122, 1483, 10.1002/ijc.23222

Angelini, 2013, Constitutive HER2 signaling promotes breast cancer metastasis through cellular senescence, Cancer Res., 73, 450, 10.1158/0008-5472.CAN-12-2301

Zacarias-Fluck, 2015, Effect of cellular senescence on the growth of HER2–positive breast cancers, J. Natl. Cancer Inst., 107, djv020, 10.1093/jnci/djv020

Di, 2014, IL-6 secreted from senescent mesenchymal stem cells promotes proliferation and migration of breast cancer cells, PLoS ONE, 9, e113572, 10.1371/journal.pone.0113572

Chen, 2005, Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis, Nature, 436, 725, 10.1038/nature03918

Alimonti, A. et al. A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis. J Clin Invest 120, 681–693

Toso, 2014, Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity, Cell Rep., 9, 75, 10.1016/j.celrep.2014.08.044

Di Mitri, 2014, Tumour-infiltrating Gr-1+myeloid cells antagonize senescence in cancer, Nature, 515, 134, 10.1038/nature13638

Hoare, 2016, NOTCH1 mediates a switch between two distinct secretomes during senescence, Nat. Cell Biol., 18, 979, 10.1038/ncb3397

Ruhland, 2016, Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis, Nat. Commun., 7, 11762, 10.1038/ncomms11762

Capell, 2016, MLL1 is essential for the senescence-associated secretory phenotype, Genes Dev., 30, 321, 10.1101/gad.271882.115

Orjalo, 2009, Cell surface-bound IL-1 alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network, Proc. Natl. Acad. Sci. U.S.A., 106, 17031, 10.1073/pnas.0905299106

Laberge, 2015, MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation, Nat. Cell Biol., 17, 1049, 10.1038/ncb3195

Herranz, 2015, mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype, Nat. Cell Biol., 17, 1205, 10.1038/ncb3225

Xu, 2015, JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age, Proc. Natl. Acad. Sci. U.S.A., 112, E6301, 10.1073/pnas.1515386112

Yosef, 2016, Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL, Nat. Commun., 7, 11190, 10.1038/ncomms11190

Cory, S. et al. Targeting BCL-2-like proteins to kill cancer cells. Trends in Cancer 2, 443–460

Chang, 2016, Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice, Nat. Med., 22, 78, 10.1038/nm.4010

Zhu, 2016, Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors, Aging Cell, 15, 428, 10.1111/acel.12445

Zhu, 2015, The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs, Aging Cell, 14, 644, 10.1111/acel.12344

Acharyya, 2012, A CXCL1 paracrine network links cancer chemoresistance and metastasis, Cell, 150, 165, 10.1016/j.cell.2012.04.042

Novakova, 2010, Cytokine expression and signaling in drug-induced cellular senescence, Oncogene, 29, 273, 10.1038/onc.2009.318

Cahu, 2012, Senescence-associated secretory phenotype favors the emergence of cancer stem-like cells, Cell Death Dis., 3, e446, 10.1038/cddis.2012.183

Vilgelm, 2016, Connecting the dots: therapy-induced senescence and a tumor-suppressive immune microenvironment, J. Natl. Cancer Inst., 108, djv406, 10.1093/jnci/djv406

Liu, 2013, Targeting aurora kinases limits tumour growth through DNA damage-mediated senescence and blockade of NF-kappaB impairs this drug-induced senescence, EMBO Mol. Med., 5, 149, 10.1002/emmm.201201378

Bertheau, 2002, Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy, Lancet, 360, 852, 10.1016/S0140-6736(02)09969-5

Bertheau, 2007, Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen, PLoS Med., 4, e90, 10.1371/journal.pmed.0040090

Chen, 2012, Value of TP53 status for predicting response to neoadjuvant chemotherapy in breast cancer: a meta-analysis, PLoS ONE, 7, e39655, 10.1371/journal.pone.0039655

Esserman, 2012, Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657), Br. Cancer Res. Treat., 132, 1049, 10.1007/s10549-011-1895-2

Wang, 2015, TP53 mutations are associated with higher rates of pathologic complete response to anthracycline/cyclophosphamide-based neoadjuvant chemotherapy in operable primary breast cancer, Int. J. Cancer, 138, 489, 10.1002/ijc.29715

Wong, 2013, Poor survival with wild-type TP53 ovarian cancer?, Gynecol. Oncol., 130, 565, 10.1016/j.ygyno.2013.06.016

Moreno, 2007, Evidence that p53-mediated cell-cycle-arrest inhibits chemotherapeutic treatment of ovarian carcinomas, PLoS ONE, 2, e441, 10.1371/journal.pone.0000441

Roberson, 2005, Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers, Cancer Res., 65, 2795, 10.1158/0008-5472.CAN-04-1270

Sidi, 2011, Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: an exploratory analysis, Eur. J. Cancer, 47, 326, 10.1016/j.ejca.2010.09.044

Wu, 2012, Accelerated cellular senescence in solid tumor therapy, Exp. Oncol., 34, 298

Bataille, 2003, Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancer, Mol. Pathol., 56, 286, 10.1136/mp.56.5.286

Choi, 2014, Identification of distinct Basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy, Cancer Cell, 25, 152, 10.1016/j.ccr.2014.01.009

Rau, 2003, Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy, J. Clin. Oncol., 21, 3391, 10.1200/JCO.2003.07.077

Tato-Costa, 2016, Therapy-induced cellular senescence induces epithelial-to-mesenchymal transition and increases invasiveness in rectal cancer, Clin. Colorectal Cancer, 15, 170, 10.1016/j.clcc.2015.09.003

Ma, 2012, Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models, J. Clin. Invest., 122, 1541, 10.1172/JCI58765

Takamori, 2000, Autocrine growth effect of IL-8 and GROalpha on a human pancreatic cancer cell line, Capan-1, Pancreas, 21, 52, 10.1097/00006676-200007000-00051

Dhawan, 2002, Role of CXCL1 in tumorigenesis of melanoma, J. Leukoc. Biol., 72, 9, 10.1189/jlb.72.1.9

Yang, 2006, Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression, Int. J. Cancer, 118, 1869, 10.1002/ijc.21596

Begley, 2008, CXCL5 promotes prostate cancer progression, Neoplasia, 10, 244, 10.1593/neo.07976

Karnoub, 2006, Chemokine networks and breast cancer metastasis, Breast Dis., 26, 75, 10.3233/BD-2007-26107

Coppe, 2006, Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence, J. Biol. Chem., 281, 29568, 10.1074/jbc.M603307200

Achuthan, 2011, Drug-induced senescence generates chemoresistant stemlike cells with low reactive oxygen species, J. Biol. Chem., 286, 37813, 10.1074/jbc.M110.200675

Basu, 2012, Role of the beta catenin destruction complex in mediating chemotherapy-induced senescence-associated secretory phenotype, PLoS ONE, 7, e52188, 10.1371/journal.pone.0052188

Jeon, 2016, Irradiation induces glioblastoma cell senescence and senescence-associated secretory phenotype, Tumour Biol., 37, 5857, 10.1007/s13277-015-4439-2

Gilbert, 2010, DNA damage-mediated induction of a chemoresistant niche, Cell, 143, 355, 10.1016/j.cell.2010.09.043